These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36264112)

  • 21. Association of Achieving Lupus Low Disease Activity State Fifty Percent of the Time With Both Reduced Damage Accrual and Mortality in Patients With Systemic Lupus Erythematosus.
    Sharma C; Raymond W; Eilertsen G; Nossent J
    Arthritis Care Res (Hoboken); 2020 Mar; 72(3):447-451. PubMed ID: 30821926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caveats and pitfalls in defining low disease activity in systemic lupus erythematosus.
    Samões B; Zen M; Abelha-Aleixo J; Gatto M; Doria A
    Autoimmun Rev; 2022 Oct; 21(10):103165. PubMed ID: 35931316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting DORIS Remission and LLDAS in SLE: A Review.
    Parra Sánchez AR; van Vollenhoven RF; Morand EF; Bruce IN; Kandane-Rathnayake R; Weiss G; Tummala R; Al-Mossawi H; Sorrentino A
    Rheumatol Ther; 2023 Dec; 10(6):1459-1477. PubMed ID: 37798595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort.
    Ugarte-Gil MF; Gamboa-Cardenas RV; Reátegui-Sokolova C; Pimentel-Quiroz VR; Medina M; Elera-Fitzcarrald C; Zevallos F; Pastor-Asurza CA; Lofland J; Zazzetti F; Karyekar CS; Alarcón GS; Perich-Campos RA
    Lupus Sci Med; 2022 Feb; 9(1):. PubMed ID: 35193948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of psychosocial stressors and psychiatric disorders with fatigue in systemic lupus erythematosus patients.
    Andayani S; Kumoroyekti T; Pradana K; Hamijoyo L
    Lupus; 2022 Oct; 31(12):1491-1497. PubMed ID: 35998900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study.
    Golder V; Kandane-Rathnayake R; Hoi AY; Huq M; Louthrenoo W; An Y; Li ZG; Luo SF; Sockalingam S; Lau CS; Mok MY; Lateef A; Franklyn K; Morton S; Navarra ST; Zamora L; Wu YJ; Hamijoyo L; Chan M; O'Neill S; Goldblatt F; Nikpour M; Morand EF;
    Arthritis Res Ther; 2017 Mar; 19(1):62. PubMed ID: 28320433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr Virus Reactivation as a New Predictor of Achieving Remission or Lupus Low Disease Activity State in Patients with Systemic Lupus Erythematosus with Cutaneous Involvement.
    Miskovic R; Cirkovic A; Miljanovic D; Jeremic I; Grk M; Basaric M; Lazarevic I; Stojanovic M; Plavsic A; Raskovic S; Banko A
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus low disease activity state as a treatment target for pediatric patients with lupus nephritis.
    Kisaoglu H; Baba O; Kalyoncu M
    Pediatr Nephrol; 2023 Apr; 38(4):1167-1175. PubMed ID: 36156735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors and prognostic stratification for lupus low disease activity state: results from a prospective clinical trial.
    Zhang K; An Y; Zhao P; Huang B; Wang Y; Zhou X; Cheng G; Xing X; Wang N; Feng R; Yu S; Li M; He J; Li Z
    Rheumatology (Oxford); 2023 Mar; 62(3):1153-1161. PubMed ID: 35895025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to Lupus Low Disease Activity State in the Hopkins Lupus Cohort: Role of African American Ethnicity.
    Babaoğlu H; Li J; Goldman D; Magder LS; Petri M
    Arthritis Care Res (Hoboken); 2020 Feb; 72(2):225-232. PubMed ID: 31507071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus.
    Oon S; Huq M; Golder V; Ong PX; Morand EF; Nikpour M
    Ann Rheum Dis; 2019 May; 78(5):629-633. PubMed ID: 30679152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of predominant Lupus Low Disease Activity State (LLDAS-50).
    Babaoglu H; Li J; Goldman D; Magder LS; Petri M
    Lupus; 2019 Dec; 28(14):1648-1655. PubMed ID: 31694446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grit personality trait of doctors and medical students in level 4 acute hospital.
    Abd Elwahab SM; Cosgrave J; Doherty E; Lowery A
    Surgeon; 2022 Aug; 20(4):216-224. PubMed ID: 34217616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between care model and disease activity states and health-related quality of life in systemic lupus erythematosus patients.
    Perea-Seoane L; Agapito-Vera E; Gamboa-Cardenas RV; Guzmán-Sánchez G; Pimentel-Quiroz VR; Reategui-Sokolova C; Medina M; Elera-Fitzcarrald C; Noriega E; Rodriguez-Bellido Z; Pastor-Asurza C; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
    Lupus; 2022 Jan; 31(1):110-115. PubMed ID: 34969318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. True grit and genetics: Predicting academic achievement from personality.
    Rimfeld K; Kovas Y; Dale PS; Plomin R
    J Pers Soc Psychol; 2016 Nov; 111(5):780-789. PubMed ID: 26867111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus.
    Yoshida M; Minowa K; Amano H; Asai Y; Yamaji K; Tamura N
    Lupus; 2021 Aug; 30(9):1378-1384. PubMed ID: 33966540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flare rates and factors determining flare occurrence in patients with systemic lupus erythematosus who achieved low disease activity or remission: results from a prospective cohort study.
    Hao Y; Ji L; Gao D; Fan Y; Geng Y; Zhang X; Li G; Zhang Z
    Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35241499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.
    Emamikia S; Oon S; Gomez A; Lindblom J; Borg A; Enman Y; Morand E; Grannas D; van Vollenhoven RF; Nikpour M; Parodis I
    Rheumatology (Oxford); 2022 Nov; 61(12):4752-4762. PubMed ID: 35302581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study.
    Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
    Arthritis Res Ther; 2020 Jan; 22(1):8. PubMed ID: 31924267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
    Tsang-A-Sjoe MW; Bultink IE; Heslinga M; Voskuyl AE
    Rheumatology (Oxford); 2017 Jan; 56(1):121-128. PubMed ID: 27803306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.